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Macrophages carry receptors on then surface for acetylated low density lipoprotein (ac-LDL) Receptor- 
mediated endocytosis of ac-LDL IS followed by intracellular cholesterol accumulation We investigated 
whether occupation of these binding sites evokes the release of hydrolytic enzymes from mouse peritoneal 
macrophages cultured for up to 48 h ac-LDL at concentrations rangmg from 25-250 c(g protem/ml was 
noted to promote m a dose-dependent fashion secretlon of the neutral protemase elastase (EC 3 4 21 37) 
and the lysosomal acid hydrolases N-acetyl$-glucosammldase (EC 3 2 1 30), j?-glucuromdase (EC 3 2 1 3 I), 
p-galactoadase (EC 3 2 1 23), a-mannosldase (EC 3 2 1 24) and cathepsm D (EC 3 4 23 5) This stlmulatory 
effect was non-cytotoxlc LDL modified by treatment with malondlaldehyde was also capable of augment- 
ing enzyme hberatlon mto culture supernates These findmgs may have lmphcatlons for some aspects of 
the atherosclerotic process 
Macrophage receptor Acetylated LDL Malondraldehyde-altered LDL Enzyme release A therosclerosls 
1. INTRODUCTION 
Macrophages of various sources and species 
have been documented to be endowed with recep- 
tors for acetylated LDL [l-4]. Binding of the 
ligand is followed by receptor-mediated en- 
docytosis. Intracellularly the lipoprotem is subject 
to lysosomal decomposition. Liberated cholesterol 
is either exported from the cell or channelled into 
the cholesterol ester cycle to undergo repetitive re- 
esterificatton and hydrolysis [5,6]. We are in- 
terested m an aspect of macrophage metabolism 
distinct from lipoprotein processing. Macrophages 
are known to be a rich source of a vartety of 
hydrolytic enzymes that are released constttutlvely 
or, for the most part, upon challenge with ap- 
propriate agents which include varied phar- 
macological compounds, microbes, immune com- 
plexes, complement components, lymphocyte- 
derived factors, and phagocytic stimuli [7,8]. 
These enzymes, when liberated into the pericellular 
environment, are instrumental in effecting tissue 
damage and medlatmg inflammatory responses 
[9]. Here we have adduced evidence to indicate 
that secretion of considerable amounts of 
lysosomal enzymes is a prominent sequela of 
macrophage stimulation elicited by chemically 
modified low density lipoproteins. 
2. MATERIALS AND METHODS 
Bovine hemoglobin type II, /?-glycerophosphate, 
,&mtrophenyl-N-acetyl-P_glucosaminide, p-nitro- 
phenyl-,&galactostde, p-nitrophenyl-a-mannoside, 
phenolphthalein-&glucuromde, porcine pancreatic 
elastase and cycloheximide were purchased from 
Sigma (Munich), mcotmamide adenine dinucleo- 
tide was obtamed from Boehringer (Mannheim), 
tetramethoxypropane from EGA Chemie, Folin- 
Ciocalteau reagent and all other chemicals were 
from Merck, Darmstadt. Dulbecco’s modified 
minimum essential medium (DMEM) was from 
Gibco (Karlsruhe), and supplemented with penicll- 
lit-r/streptomycin (100 U/ml). 
LDL (density 1.019-1.063 g/ml) was obtained 
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from human plasma of normolipidemic volunteers 
and prepared by differential ultracentrifugation in 
a Beckman L8-70 ultracentrifuge [lo]. LDL was 
acetylated by repeat additions of acetic anhydride 
as described [l l] and modified by treatment with 
malondialdehyde according to [ 121. After chemical 
modification, dialysis was performed against 
0.15 M NaCl and 0.3 mM EDTA, pH 7.4. 
Acetylated and malondialdehyde-modified LDL 
exhibited enhanced mobility on agarose gel elec- 
trophoresis in barbital buffer, pH 8.6. Cells were 
collected from the peritoneal cavity of 6-week-old 
female NMRI mice (Zentrale Tierversuchsanlage, 
Universitat Dusseldorf) by rinsing with DMEM 
containing 5 U/ml heparin (Nordmark, Ham- 
burg), spun down at 400 x g, resuspended at a con- 
centration of 2 x 106/ml, and then seeded into 
Cluster 24 multi-well culture dishes (Costar, Cam- 
bridge, MA). Following an initial 3 h adherence 
period, non-adherent cells were removed by several 
washes with medium. Monolayers consisted of 
91-95% macrophages as evidenced by staining for 
nonspecific esterase and latex phagocytosis 
[13,14]. Cells were then challenged with modified 
LDL and cultured for up to 48 h. Cell-free super- 
nates and cell lysates prepared by addition of 0.1% 
Triton X-100 were then assayed for activity of the 
enzymes elastase [ 151, N-acetyl-,&glucosaminidase, 
P-glucuronidase, fl-galactosidase, cathepsin D, 
acid phosphatase (EC 3.1.3.2) and cu-mannosidase 
[ 161. Cell viability was assessed by determination 
of lactate dehydrogenase (EC 1.1.1.27) release into 
supernates [17]. Results were corrected for cell 
number by correlation with DNA content of 
monolayers, lo6 macrophages yielding 11 pg DNA 
1181. 
3. RESULTS 
Macrophages were exposed to various amounts 
of ac-LDL ranging from 12.5 to 250,ug/ml. With 
the notable exception of acid phosphatase, release 
of all enzymes tested was augmented in response to 
ac-LDL (table 1) although to a varying extent. A 
detailed dose-response curve is given in fig. 1. It is 
apparent that a maximal stimulatory effect on the 
secretion is achieved by addition of 250 pg/ml ac- 
LDL, the EDso approximating lOOpg/ml. The 
broad spectrum of enzymes liberated from 
macrophages after exposure to 250 /g/ml ac-LDL 
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Table I 
Enzyme release from macrophages challenged with modified 
LDL 














2.8 f 0.4a 0.2 + 0.05 
3.0 -t Osb 1.2 + 0.2 
2.9 + 0.4’ 0.8 + 0.15 
2.1 * 0.35 0.1 f 0.04 
2.2 * 0.4 0.6 k 0.15 
2.1 & 0.3 0.4 + 0.1 
13.8 + 1.8 0.7 + 0.1 
15.1 * 2.1 4.3 f 0.9 
13.6 + 1.5 3.3 + 0.6 
52.5 * 3.9 
56.5 & 4.3 
53.5 * 3.7 
39.7 + 6.4 
48.3 f 8.7 
45.4 + 7.5 
0.72 + 0.08 
0.87 + 0.1 
0.82 + 0.09 
5.0 -t 0.8 
5.1 + 0.9 
4.9 -t 0.7 
157.2 k 28.7 
211.5 k 37.9 
187.9 + 31.1 
0.09 It_ 0.01 
0.12 + 0.01 
0.11 + 0.01 
Macrophages were exposed to medium (” controls), ac-LDL 
(250 pg/ml); b or malondialdehyde-modified LDL (250 pg/ 
ml); ’ for a period of 48 h, whereafter cell lysates and super- 
nates were examined for enzyme activities. Results are means 
+ SD of 3 experiments 
can be seen in table 1. The requirement for de novo 
synthesis was demonstrated by experiments in 
which macrophages were incubated in the 
simultaneous presence of ac-LDL and the protein 
synthesis inhibitor cycloheximide (1 pg/ml). Ac- 
tivity in culture supernatants of all enzymes tested 
decreased to almost zero after addition of 
cycloheximide (not shown). It should be noted that 
ac-LDL mediated release of macrophage enzymes 
was not due to increased leakage subsequent to 
toxic damage inflicted upon these cells by exposure 
to the lipoprotein. The non-cytotoxic nature of its 
stimulatory effect was proven by showing that lac- 
tate dehydrogenase activity in culture supernatants 
was virtually unchanged when compared to control 







I ! I I I I 50 100 150 200 250 
mnt ac-LDL (~ghlll 
Fig 1. Dose relatronshrp of ac-LDL-evoked enzyme 
secretion. Release of the lysosomal enzyme N-acetyl-fl- 
glucosammrdase mto supernates of adherent macro- 
phages was determined after 48 h of mcubatton wtth 
indicated amounts of acetylated LDL under serum-free 
condrttons Results are expressed m % of total enzyme 
acttvtty (1 e mtra- + extracellular) and represent means 
f SD of 3 experiments 
incubates. When kinetic studres were performed 
sampling supernates every 8 h following challenge 
of macrophages with ac-LDL, it was found that ht- 
tle secretion took place during the first 24 h 
whereafter enzyme release considerably ac- 
celerated to plateau off at about 40 h (frg.2). 
Malondraldehyde-modified LDL, which apparent- 
ly also binds to the recogmtron site for ac-LDL 
[6,12], was also effective m uutratmg liberation of 
“lM 
I 
I I I 
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Fig 2 Kmettcs of enzyme secretton Macrophage 
cultures were challenged wrth 250pg/ml ac-LDL and 
Incubated for up to 48 h At timed Intervals supernates 
were collected and evaluated for acttvrty of the enzyme 
N-acetyl-,&glucosamnudase. Results are gtven per lo6 
cells and represent means of quadruphcate cultures 
all hydrolases gauged except acid phosphatase 
(table 1). However, equi-effective doses of this 
lipoprotein tended to be higher. 
4 DISCUSSION 
Following the pioneering work of Goldstem and 
Brown (review [6]) it has been amply documented 
that cells of the monocyte-macrophage lineage are 
an important site of lipoprotein metabolism. Ex- 
pression on the surface of these cells of so-called 
scavenger eceptors recognizing modified LDL has 
so far been related only to then function in pro- 
moting clearance and intracellular processmg of 
hpoprotems. Scavenger eceptors are considered to 
be instrumental m the accumulatron of cholesteryl 
esters m macrophages. Here we have focused our 
interest on a different aspect of macrophage 
metabolism and put forth evidence that strmula- 
tton of the scavenger eceptor results m the secre- 
tion of a number of lysosomal enzymes. Kinetics 
and requirement for de novo synthesis of these 
novel actions displayed by both ac-LDL and 
malondialdehyde-LDL are in accord with results 
from previous studies examining other inducers of 
enzyme release from macrophages [7,8,19-211. 
How occupancy of the bmdmg sttes for modified 
LDL results m the generation and propagation of 
the signal to evoke lysosomal enzyme syntheses and 
hberatron is yet to be elucidated. 
Very early m the atherosclerotrc process 
monocyte-macrophages enter the arterial wall at 
sites of altered endothehal permeability [22] We 
suggest hat our findings, estabhshmg lipoproteins 
as activators of macrophage nzyme release, may 
be stgmfrcant o the pathogenests of atherosclero- 
sis. Interaction of these cells with hpoprotems, 
which leak through the damaged lummal vessel 
hnmg with ensuing release of tissue and cell 
degrading hydrolases, might conceivably initiate, 
accentuate or perpetuate endothehal injury and 
thereby accelerate development of atherosclerotrc 
plaque lesions. 
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